Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Rhabdomyolysis? 53 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Rhabdomyolysis have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.0% of all adverse event reports for CYCLOPHOSPHAMIDE.

53
Reports of Rhabdomyolysis with CYCLOPHOSPHAMIDE
0.0%
of all CYCLOPHOSPHAMIDE reports
12
Deaths
40
Hospitalizations

How Dangerous Is Rhabdomyolysis From CYCLOPHOSPHAMIDE?

Of the 53 reports, 12 (22.6%) resulted in death, 40 (75.5%) required hospitalization, and 20 (37.7%) were considered life-threatening.

Is Rhabdomyolysis Listed in the Official Label?

Yes, Rhabdomyolysis is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Rhabdomyolysis?

ATORVASTATIN (3,286) ROSUVASTATIN (2,173) SIMVASTATIN (1,616) LEVETIRACETAM (1,183) QUETIAPINE (971) OLANZAPINE (647) ACETAMINOPHEN (630) METFORMIN (603) RISPERIDONE (527) ARIPIPRAZOLE (516)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Rhabdomyolysis Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Rhabdomyolysis Reports All Drugs Causing Rhabdomyolysis CYCLOPHOSPHAMIDE Demographics